Entire Transcript in Adobe Acrobat Format - National Reference ...

90
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
willing to do, you know, look at the frequency of some
allele in some certain population, they do not need
identifiers, but if they want to come in and they want to
find in this, that and this certain polymorphisms they will
probably need identifiers. They would have to go back to
the IRB with a whole new proposal and it would be up to the
new study coming in to the parent study -- now the parent
study does not lose their identifiers. I mean, these
samples are identifiable because they are for a research
study but the new study coming in would either obtain
identifiers or they would be anonymous depending on what
their proposal is and then how do they proceed.
DR. HOLTZMAN: We need to be very clear on
that. Now if the Framingham -- at least my understanding
is the Framingham samples are not anonymized. If I come in
and say I would like to use those samples, all right, I do
not care about having identifiers. Even with respect to my
use those identifiers are stripped.
DR. OLD: With respect to your use.
DR. HOLTZMAN: My use.
DR. OLD: Right.
DR. HOLTZMAN: Okay.
DR. OLD: You would have no --
DR. HOLTZMAN: All right. So in your